menu search

Spy turns bearish and vix turns bullish (technical analysis downgrade)

SPY has started a bearish move down, forming a bearish pattern of lower highs and lower lows. High inte...

September 24, 2023, 4:10 am

Genuine parts company: growth to continue at the current mid-single-digit pace.

GPC operates in two key segments, the Automotive Parts Group (APG) and the Industrial Parts Group (IPG), with APG contributing around 60% of EBIT and ...

September 24, 2023, 2:44 am

Primerica and comfort systems usa: 2 fast-growing dividends worth investors' attention

Investors can often be classified as growth or income investors, with dividend growth investors falling in between. Primerica Inc. and Comfort Systems...

September 24, 2023, 2:43 am

The case for bitcoin (btc) despite the ~61% price crash

Bitcoin (BTC) price has gone through a rough patch in the past two years. After peaking near $68,000 in...

September 23, 2023, 8:29 pm

Next avenue: how do healthcare and medicare work when you retire abroad?

Imagine paying just a 10th of what you’d pay in the U.S. for professional, personal and prompt healthcare. Here’s how it works for one ex...

September 23, 2023, 3:42 pm

Play of the day recaps: sept. 18 – 21, 2023

It was a crazy week of catalysts but our strategists anticipated directional biases & turning points pr...

September 23, 2023, 3:04 pm

Is iphone 15 going to ‘move the needle' for apple stock?

As the anticipated iPhone 15 hits the shelves, investors are watching how this latest release will impa...

September 23, 2023, 11:46 am

Ascendis pharma presents results from long-term enlighten trial of transcon™ hgh in pediatric growth hormone deficiency

– The majority of children and adolescents treated once weekly with TransCon hGH (lonapegsomatropin) met or exceeded average parental height SDS at ...

September 23, 2023, 11:00 am

Verallia: trading at a 13% free cash flow yield and 8x earnings

Verallia's H1 results exceeded expectations, with a total organic revenue increase of almost 29%. The company's EBITDA and free cash flow were stronge...

September 23, 2023, 10:40 am

Usd/cad weekly outlook

USD/CAD’s deep decline last week argues that rise from 1.3091 might have completed at 1.3693 already. Fall from there is probably another leg in the...

September 23, 2023, 9:04 am

Meta stock leads 5 names showing resilience in market downturn

Meta leads five resilient stocks worth watching. But investors need to be patient amid the market corre...

September 23, 2023, 8:00 am

The case for bitcoin (btc) despite the ~61% crash

Bitcoin (BTC) price has gone through a rough patch in the past two years. After peaking near $68,000 in...

September 23, 2023, 7:59 am

Local equities may take longer to recover

The Stock Exchange of Thailand has fallen further below key psychological supports, suggesting any recovery in the local equity market will be slower ...

September 23, 2023, 1:44 am

Rosen, nationally regarded investor counsel, encourages uipath, inc. investors to secure counsel before important deadline in securities class action – path

NEW YORK, Sept. 22, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ui...

September 23, 2023, 12:27 am

Us stocks close at lowest since june, treasury yields spike on hawkish fed

Wall Street tanked in a broad sell-off on Thursday, as investor risk appetite was dashed by worries that the Federal Reserve’s restrictive monetary ...

September 22, 2023, 11:44 pm

Statehouse announces fall 2023 conference participation

Announces Upcoming Change to Auditors SAN DIEGO and TORONTO, Sept. 22, 2023 (GLOBE NEWSWIRE) — StateHouse Holdings Inc. (“StateHouse” or the “...

September 22, 2023, 10:41 pm

Morphic to present positive emerald-1 phase 2a data for morf-057 in patients with moderate to severe ulcerative colitis in abstract for uegw 2023

-Orally administered MORF-057 achieved primary endpoint and demonstrates clinically meaningful improvements across secondary and exploratory measures-...

September 22, 2023, 9:30 pm

Aldeyra:upcoming pdufa, strong nda, long pipeline, decent cash

Aldeyra is a late-stage company developing therapies for immune-mediated diseases, with a focus on dry eye disease and allergic conjunctivitis. Their ...

September 22, 2023, 7:44 pm

Qse treads flat path amid buying interests in five of seven sectors islamic equities outperform

In the venture market, trade volumes more than tripled to 11.76mn equities and value more than doubled to QR13.36mn on 14% jump in transactions to 487...

September 22, 2023, 6:59 pm


Search within

Pages Search Results: